Sirolimus: a new agent for clinical renal transplantation.
Kahan
B D
BD
Department of Surgery, University of Texas Medical School at Houston 77030, USA.
D000818:Animals; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D011090:Polyenes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020123:Sirolimus; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D020123:Sirolimus